OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
Jean–Luc Van Laethem, Ivan Borbath, Hans Prenen, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 7, pp. 853-864
Closed Access | Times Cited: 9
Jean–Luc Van Laethem, Ivan Borbath, Hans Prenen, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 7, pp. 853-864
Closed Access | Times Cited: 9
Showing 9 citing articles:
Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 11
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 11
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma
Paul David, Dina Kouhestani, Frederik J. Hansen, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1500-1500
Open Access
Paul David, Dina Kouhestani, Frederik J. Hansen, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1500-1500
Open Access
Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
Tarık Demır, Carolyn Moloney, Devalingam Mahalingam
Cancers (2025) Vol. 17, Iss. 5, pp. 715-715
Open Access
Tarık Demır, Carolyn Moloney, Devalingam Mahalingam
Cancers (2025) Vol. 17, Iss. 5, pp. 715-715
Open Access
Pancreatic cancer
Thomas F. Stoop, Ammar A. Javed, Atsushi Oba, et al.
The Lancet (2025) Vol. 405, Iss. 10485, pp. 1182-1202
Closed Access
Thomas F. Stoop, Ammar A. Javed, Atsushi Oba, et al.
The Lancet (2025) Vol. 405, Iss. 10485, pp. 1182-1202
Closed Access
Novel Therapies for Pancreatic Cancer
Victoria Chung, Jonathan D. Mizrahi, Shubham Pant
JCO Oncology Practice (2024)
Closed Access | Times Cited: 1
Victoria Chung, Jonathan D. Mizrahi, Shubham Pant
JCO Oncology Practice (2024)
Closed Access | Times Cited: 1
Small steps can lead to substantial breakthroughs: moving the therapeutic needle forward in pancreatic cancer
Priyadarshini Pathak, Colin D. Weekes, Jennifer Y. Wo
The Lancet Oncology (2024) Vol. 25, Iss. 7, pp. 824-825
Closed Access | Times Cited: 1
Priyadarshini Pathak, Colin D. Weekes, Jennifer Y. Wo
The Lancet Oncology (2024) Vol. 25, Iss. 7, pp. 824-825
Closed Access | Times Cited: 1
Exogenous or in situ vaccination to trigger clinical responses in pancreatic cancer
Gregory L. Beatty, Elizabeth M. Jaffee
Carcinogenesis (2024) Vol. 45, Iss. 11, pp. 826-835
Closed Access | Times Cited: 1
Gregory L. Beatty, Elizabeth M. Jaffee
Carcinogenesis (2024) Vol. 45, Iss. 11, pp. 826-835
Closed Access | Times Cited: 1
Drug combinations of camptothecin derivatives promote the antitumor properties
Zhen Liu, Yajie Yuan, Ning Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116872-116872
Closed Access
Zhen Liu, Yajie Yuan, Ning Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116872-116872
Closed Access
